| For the year ended March 31 | 2009 | 2008 |
| Cash Provided by (used in): | | |
| | | |
| Operations |
| |
| Cash received from Natural Sciences and Engineering
Research Council of Canada/ICP | $ 9,700,000 | 9,700,060 |
| Cash received from other sources | 743,662 | 1,817,195 |
| Interest received | 81,476 | 132,380 |
| Cash paid to suppliers and employees | (9,361,978) | (10,034,364) |
| | 1,163,160 | 1,615,271 |
| | | |
| Investments | | |
| Purchase of capital assets | (397,463) | (201,953) |
| Investment in DMT Microsystems Corporation | - | (10,010) |
| Write off capital assets
| 350,381 | - |
| Write off accumulated amortization | (251,182) | - |
| | (298,264)
| (211,963) |
| | | |
| Increase in cash and cash equivalents during the year | 864,896
| 1,403,308 |
| | | |
| Cash and cash equivalents, beginning of year | 3,826,679 | 2,423,371 |
| | | |
| Cash and cash equivalents, end of year | $ 4,691,575 | $ 3,826,679 |
| | | |
| Represented by: | | |
| Cash | 3,246,135 | 2,607,545 |
| Funds on deposit with Queen's University | 1,445,440 | 1,219,134 |
| | $ 4,691,575 | $ 3,826,679 |